FUNDING INFORMATION
Cancer
CANCER
Hospital Sírio‐Libanês sponsored this trial and provided the non‐invasive hemodynamic device. The study was part‐funded by National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748 to Natally Horvat. The AutEMdev was provided by Autem Therapeutics under a research development agreement with Hospital Sírio‐Libanês. Medical writing support was provided by Oxford PharmaGenesis, Oxford, UK, funded by Autem Therapeutics. Clinical records were reviewed by an independent auditor from Emergo (Austin, TX, USA) and radiological review was conducted by an independent blinded radiologist from Charité–Universitätsmedizin Berlin (Berlin, Germany), funded by Autem Therapeutics.